Inventors: Rajeev Sakhuja

In Part II of the drug development process, the focus lies on designing and synthesizing impurities of the active pharmaceutical ingredient (API). This critical step involves the creation of specific impurities to further understand the structural and chemical characteristics of the API, contributing significantly to the overall progress of drug.